Ensysce Biosciences Inc. (ENSC) NASDAQ

$0.57 (0.01) (-1.59%)

Market Cap: $4.18M

As of 04/19/24 04:00 PM EDT. Market closed.

(ENSC)

Ensysce Biosciences Inc. (ENSC)
NASDAQ

$0.57
(0.01) (-1.59%)

Market Cap: $4.18M

As of 04/19/24 04:00 PM EDT. Market closed.

Add to Portfolio

ensysce biosciences, san diego, ca, is an integrated drug delivery company for both small and large molecules. to overcome the major problem of non-medical use of opioid products, ensysce is using its prodrug technology to improve abuse deterrent properties. the tap bio-md™ abuse deterrent and mpar™ overdose resistant pain platforms, with worldwide intellectual patent protection, eliminate ... read more

ensysce biosciences, san diego, ca, is an integrated drug delivery company for both small and large molecules. to overcome the major problem of non-medical use of opioid products, ensysce is using its prodrug technology to improve abuse deterrent properties. the tap bio-md™ abuse deterrent and mpar™ overdose resistant pain platforms, with worldwide intellectual patent protection, eliminate the ability to abuse opioid products by the non-oral route. this abuse is the fastest growing drug problem in the u.s. and it leads to billions in healthcare costs annually. for additional information about ensysce biosciences please visit www.ensysce.com. read less

COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
Full Time Employees
4
URL
Address
.
PRICE CHART FOR ENSYSCE BIOSCIENCES INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.57
Previous Close
$0.58
Days Range
$0.54 - $0.61
52 week range
$0.53 - $7.20
Volume
187,232
Avg. Volume (30 days)
107,803
Market Cap
$4.18M
Dividend Yield
-
P/E
(0.39)
Shares Outstanding
7,329,172
Open
$0.57
Previous Close
$0.58
Days Range
$0.54 - $0.61
52 week range
$0.53 - $7.20
Volume
187,232
Avg. Volume (30 days)
107,803
Market Cap
$4.18M
Dividend Yield
-
P/E
(0.39)
Shares Outstanding
7,329,172
FINANCIAL STATEMENTS FOR ENSYSCE BIOSCIENCES INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ENSYSCE BIOSCIENCES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
GOWER BOB GDirectorMar 02, 2023 Buy$0.4990,28744,0871,222,682Mar 06, 2023, 04:33 PM
GOWER BOB GDirectorMar 01, 2023 Buy$0.48270,000128,9791,132,395Mar 02, 2023, 03:45 PM
GOWER BOB GDirectorFeb 28, 2023 Buy$0.49109,30053,371862,395Mar 02, 2023, 03:45 PM
GOWER BOB GDirectorDec 09, 2022 Buy$1.40357,143500,000753,095Feb 01, 2023, 06:06 PM
Kirkpatrick LynnChief Executive OfficerMay 26, 2022 Buy$0.5327,00014,215381,851May 27, 2022, 02:05 PM
Kirkpatrick LynnChief Executive OfficerMay 25, 2022 Buy$0.4970,00034,083354,851May 27, 2022, 02:05 PM
HG Vora Capital Management, LLC10% OwnerDec 01, 2017 Buy$10.001,000,00010,000,0003,837,500Jan 17, 2018, 05:39 PM
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
GOWER BOB GDirector03/02/202344,087
GOWER BOB GDirector03/01/2023128,979
GOWER BOB GDirector02/28/202353,371
GOWER BOB GDirector12/09/2022500,000
Kirkpatrick LynnChief Executive Officer05/26/202214,215
Kirkpatrick LynnChief Executive Officer05/25/202234,083
HG Vora Capital Management, LLC10% Owner12/01/201710,000,000
FUNDS WITH A POSITION IN ENSYSCE BIOSCIENCES INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
GEODE CAPITAL MANAGEMENT, LLC16,2810%-0.91%Other
RENAISSANCE TECHNOLOGIES LLC10,9570.00002%NewOther
BLACKROCK INC.9750%No changeOther
CHANGE IN SHARES OUTSTANDING FOR ENSYSCE BIOSCIENCES INC
STOCK BUYBACKS FOR ENSYSCE BIOSCIENCES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
-15.11%
1Q
12/31/2023
06/30/2023
15.20%
2Q

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
-15.11%
1Q
06/30/2023
15.20%
2Q
BUYBACK ANNOUNCEMENT(S) FOR ENSYSCE BIOSCIENCES INC
LOADING...